Peter J. Syribeys

579 total citations
8 papers, 457 citations indexed

About

Peter J. Syribeys is a scholar working on Infectious Diseases, Molecular Biology and Epidemiology. According to data from OpenAlex, Peter J. Syribeys has authored 8 papers receiving a total of 457 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Infectious Diseases, 5 papers in Molecular Biology and 4 papers in Epidemiology. Recurrent topics in Peter J. Syribeys's work include Antimicrobial Resistance in Staphylococcus (8 papers), Streptococcal Infections and Treatments (4 papers) and Biochemical and Structural Characterization (3 papers). Peter J. Syribeys is often cited by papers focused on Antimicrobial Resistance in Staphylococcus (8 papers), Streptococcal Infections and Treatments (4 papers) and Biochemical and Structural Characterization (3 papers). Peter J. Syribeys collaborates with scholars based in United States. Peter J. Syribeys's co-authors include John Vernachio, Joseph M. Patti, Elena Gorovits, Andrea Hall, Brenda Ames, Arnold S. Bayer, Paul Domanski, Jeff Hutchins, Bradley D. Prater and Pratiksha Patel and has published in prestigious journals such as The Journal of Infectious Diseases, Antimicrobial Agents and Chemotherapy and Infection and Immunity.

In The Last Decade

Peter J. Syribeys

8 papers receiving 427 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Peter J. Syribeys United States 7 350 265 114 92 79 8 457
Jawad Sarwar United States 9 363 1.0× 278 1.0× 88 0.8× 107 1.2× 172 2.2× 15 596
Axana Haggar Sweden 11 411 1.2× 306 1.2× 169 1.5× 80 0.9× 72 0.9× 11 569
Yuru Shi China 8 265 0.8× 199 0.8× 66 0.6× 85 0.9× 56 0.7× 16 431
Carla Emolo United States 10 251 0.7× 277 1.0× 173 1.5× 48 0.5× 153 1.9× 10 512
Jasdeep S. Nanra United States 6 238 0.7× 179 0.7× 43 0.4× 41 0.4× 63 0.8× 7 326
Deborah A. Dilts United States 9 166 0.5× 144 0.5× 54 0.5× 55 0.6× 125 1.6× 11 383
Katherine J. Kasper Canada 13 271 0.8× 113 0.4× 219 1.9× 152 1.7× 50 0.6× 18 532
Julie Zorman United States 9 206 0.6× 150 0.6× 44 0.4× 52 0.6× 33 0.4× 10 314
Mark Reglinski United Kingdom 10 171 0.5× 84 0.3× 194 1.7× 52 0.6× 73 0.9× 17 408
Chanelle Ryan United States 10 319 0.9× 252 1.0× 48 0.4× 89 1.0× 34 0.4× 11 497

Countries citing papers authored by Peter J. Syribeys

Since Specialization
Citations

This map shows the geographic impact of Peter J. Syribeys's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peter J. Syribeys with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peter J. Syribeys more than expected).

Fields of papers citing papers by Peter J. Syribeys

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Peter J. Syribeys. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peter J. Syribeys. The network helps show where Peter J. Syribeys may publish in the future.

Co-authorship network of co-authors of Peter J. Syribeys

This figure shows the co-authorship network connecting the top 25 collaborators of Peter J. Syribeys. A scholar is included among the top collaborators of Peter J. Syribeys based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Peter J. Syribeys. Peter J. Syribeys is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

8 of 8 papers shown
1.
Hall, Andrea, Pratiksha Patel, Paul Domanski, et al.. (2007). A Panel of Monoclonal Antibodies Recognizing the Staphylococcus epidermidis Fibrinogen-Binding MSCRAMM SdrG. Hybridoma. 26(1). 28–34. 5 indexed citations
2.
Hall, Andrea, Elena Gorovits, Peter J. Syribeys, et al.. (2007). Monoclonal antibodies recognizing the Enterococcus faecalis collagen-binding MSCRAMM Ace: Conditional expression and binding analysis. Microbial Pathogenesis. 43(2-3). 55–66. 22 indexed citations
3.
Vernachio, John, Arnold S. Bayer, Brenda Ames, et al.. (2006). Human Immunoglobulin G Recognizing Fibrinogen-Binding Surface Proteins Is Protective against both Staphylococcus aureus and Staphylococcus epidermidis Infections In Vivo. Antimicrobial Agents and Chemotherapy. 50(2). 511–518. 55 indexed citations
4.
Domanski, Paul, Pratiksha Patel, Arnold S. Bayer, et al.. (2005). Characterization of a Humanized Monoclonal Antibody Recognizing Clumping Factor A Expressed by Staphylococcus aureus. Infection and Immunity. 73(8). 5229–5232. 59 indexed citations
5.
Höök, Magnus, David L. Haviland, Rick A. Wetsel, et al.. (2004). Inhibition of Complement Activation by a SecretedStaphylococcus aureusProtein. The Journal of Infectious Diseases. 190(3). 571–579. 104 indexed citations
6.
Liu, Yule, Brenda Ames, Elena Gorovits, et al.. (2004). SdrX, a Serine-Aspartate Repeat Protein Expressed by Staphylococcus capitis with Collagen VI Binding Activity. Infection and Immunity. 72(11). 6237–6244. 19 indexed citations
7.
Hall, Andrea, Paul Domanski, Pratiksha Patel, et al.. (2003). Characterization of a Protective Monoclonal AntibodyRecognizing Staphylococcus aureus MSCRAMM ProteinClumping FactorA. Infection and Immunity. 71(12). 6864–6870. 112 indexed citations
8.
Vernachio, John, Arnold S. Bayer, Thuan Le, et al.. (2003). Anti-Clumping Factor A Immunoglobulin Reduces the Duration of Methicillin-ResistantStaphylococcus aureusBacteremia in an Experimental Model of Infective Endocarditis. Antimicrobial Agents and Chemotherapy. 47(11). 3400–3406. 81 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026